Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 15;2(2):129-136.
doi: 10.1002/ags3.12061. eCollection 2018 Mar.

Recent updates in the surgical treatment of colorectal cancer

Affiliations
Review

Recent updates in the surgical treatment of colorectal cancer

Takeru Matsuda et al. Ann Gastroenterol Surg. .

Abstract

Because of recent advances in medical technology and new findings of clinical trials, treatment options for colorectal cancer are evolutionally changing, even in the last few years. Therefore, we need to update the treatment options and strategies so that patients can receive optimal and tailored treatment. The present review aimed to elucidate the recent global trends and update the surgical treatment strategies in colorectal cancer by citing the literature published in the last 2 years, namely 2016 and 2017. Although laparoscopic surgery is still considered the most common approach for the treatment of colorectal cancer, new surgical technologies such as transanal total mesorectal excision, robotic surgery, and laparoscopic lateral pelvic lymph node dissection are emerging. However, with the recent evidence, superiority of the laparoscopic approach to the open approach for rectal cancer seems to be controversial. Surgeons should notice the risk of adverse outcomes associated with unfounded and uncontrolled use of these novel techniques. Many promising results are accumulating in preoperative and postoperative treatment including chemotherapy, chemoradiotherapy, and targeted therapy. Development of new biomarkers seems to be essential for further improvement in the treatment outcomes of colorectal cancer patients.

Keywords: colorectal cancer; laparoscopic surgery; lateral pelvic lymph node dissection; robotic surgery; transanal total mesorectal excision.

PubMed Disclaimer

References

    1. Brody H. Colorectal cancer. Nature. 2015;521:S1. - PubMed
    1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683–91. - PubMed
    1. Guillou PJ, Quirke P, Thorpe H, et al. Short‐term endpoints of conventional versus laparoscopic‐assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–26. - PubMed
    1. Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic‐assisted resection of colorectal carcinoma: 3‐year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25:3061–8. - PubMed
    1. Kitano S, Inomata M, Mizusawa J, et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2017;2:261–8. - PubMed

LinkOut - more resources